Annual meeting


June 26th, 2025

ImmunoMetNet annual meeting in the O2 building auditorium at VUmc, Amsterdam UMC


June 27th, 2025

Workshops provided by our sponsors and collaborators (indicate your interest during registration)


REGISTER NOW


Program

Thursday June 26th 9 am – 5 pm : ImmunoMetNet annual meeting, followed by drinks

Friday June 27th : workshops on Seahorse metabolic flux analysis and drug development kindly provided by our sponsors and collaborators.

We reserved some spots for junior and senior researchers who want to present their new immunometabolism-related work. Please indicate this during your registration.

Confirmed speakers:

  • Charlotte Scott (VIB, Ghent, Belgium) – Understanding the functional heterogeneity of hepatic macrophages in metabolic disease
  • Dylan Ryan (University of Cambridge, UK) – Mitochondrial conrtol of inflammatory macrophage function
  • Jade Bailey (Sitryx, Oxford, UK) – Targeting Immunometabolism in Chronic Inflammatory Diseases
  • Kim Bonger (Leiden University) – Metabolic protein labelling using bioorthogonal threonine analogues
  • Sabine Daemen (Maastricht University) – Lipid-Associated Macrophages; key regulators of MASH and liver fibrosis?
  • Bart Eggen (UMC Groningen) – Microglia, the immune sentinels of the CNS from an -omics perspective
  • Martin Giera (Leiden UMC) – Cholesterol biosynthesis as anti-inflammatory target
  • Olaf Perdijk (Utrecht University) – Modulating respiratory immunity through microbial priming of the epithelium
  • Annemiek van Spriel (Radboud UMC, Nijmegen) – Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37
  • Hanneke Willemen (UMC Utrecht) – Neuron-macrophage crosstalk; the contributions of mitochondria to active pain resolution and persistent pain
  • Dixie Bakker | Marian van Roon (Amsterdam UMC) – Pgm1 as modulator of inflammatory response of macrophages in experimental pneumococcal meningitis
  • Robin Kramer (Radboud UMC) – BCG and beta-glucan steer moDC function towards the induction of tolerogenic immune responses